Brief
Burjeel Holdings launches International Hematology Institute in Abu Dhabi
The institute will combine patient care, research and education under the leadership of a world‑renowned hematology expert.
By Felo News Desk · Published
Burjeel Holdings, a leading super‑specialty healthcare provider in the Gulf, announced the creation of an International Hematology Institute in the UAE, with its flagship hub at Burjeel Medical City in Abu Dhabi. The institute will be headed by Prof. Alok Srivastava, a globally recognised pioneer in hematology, stem‑cell transplantation and gene‑therapy research, according to Gulf News.
What happened
The institute is part of Burjeel’s "Burjeel 2.0" transformation strategy, which aims to develop advanced clinical capabilities and globally competitive specialty centres. It will bring together existing clinical expertise and research capacity to treat complex blood disorders, perform bone‑marrow and stem‑cell transplants, and develop emerging cell and gene therapies. Prof. Srivastava has been appointed Chairman of the Group‑Wide Hematology Institute and will oversee an integrated platform covering hematology, hemato‑oncology, bone‑marrow transplantation and related advanced therapies.
What the reports add
Gulf News notes that Prof. Srivastava spent more than 35 years at Christian Medical College in Vellore, India, where he helped build one of the country’s leading bone‑marrow transplantation programmes and founded the Centre for Stem Cell Research, a unit of India’s Institute for Stem Cell Science and Regenerative Medicine (inStem). The outlet also highlights his role in shaping the World Federation of Hemophilia’s (WFH) Guidelines for the Management of Hemophilia, having led the development of all three editions. In addition, his recent accolades include the International Society on Thrombosis and Haemostasis (ISTH) Esteemed Career Award in 2024 and service on the WFH Board of Directors.
What was said
Gulf News quoted the announcement that Prof. Srivastava will "spearhead the development of an integrated clinical and academic platform" and that the institute will "strengthen specialist referrals, multidisciplinary treatment and access to advanced care".
How it came about
The launch follows Burjeel Holdings’ broader push to expand specialty services across the GCC, building on earlier investments in super‑specialty hospitals and partnerships. The institute’s focus on cutting‑edge therapies aligns with the UAE’s national health strategy, which seeks to position the country as a regional hub for advanced medical treatment and research.
Key facts
- Burjeel Holdings is developing an International Hematology Institute in Abu Dhabi. (gulfnews.com)
- Prof. Alok Srivastava will serve as Chairman of the Group‑Wide Hematology Institute. (gulfnews.com)
- The institute will focus on complex blood disorders, stem‑cell transplantation and gene‑therapy research. (gulfnews.com)
- Prof. Srivastava spent over 35 years at Christian Medical College, Vellore, and led the Centre for Stem Cell Research. (gulfnews.com)
- He helped develop all three editions of the World Federation of Hemophilia's Guidelines for the Management of Hemophilia. (gulfnews.com)
Sources
- [1] gulfnews.com — originally reported as “Prof. Alok Srivastava to build International Hematology Institute in UAE”
